131 related articles for article (PubMed ID: 191406)
1. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.
Fresen KO; Merkt B; Bornkamm GW; Hausen H
Int J Cancer; 1977 Mar; 19(3):317-23. PubMed ID: 191406
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
zur Hausen H; Fresen KO
IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
[TBL] [Abstract][Full Text] [Related]
3. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
4. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
5. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
6. Molecular size variation of EBNA is determined by the EB viral genome.
Gergely L; Sternås L; Dillner J; Klein G
Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
9. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
Leinbach SS; Summers WC
J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
[TBL] [Abstract][Full Text] [Related]
11. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
12. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
Klein G; Falk L; Falk K
Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
[TBL] [Abstract][Full Text] [Related]
13. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
Moar MH; Ber R; Klein G; Westman A; Eriksson I
Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
[TBL] [Abstract][Full Text] [Related]
14. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
Lin JC; Choi EI; Pagano JS
J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
[TBL] [Abstract][Full Text] [Related]
16. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
Moar MH; Klein G
Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines.
Ernberg I; Klein G; Giovanella BC; Stehlin J; McCormick KJ; Andersson-Anvret M; Aman P; Killander D
Int J Cancer; 1983 Feb; 31(2):163-9. PubMed ID: 6298125
[TBL] [Abstract][Full Text] [Related]
18. Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells.
Cho MS; Bornkamm GW; zur Hausen H
J Virol; 1984 Jul; 51(1):199-207. PubMed ID: 6328039
[TBL] [Abstract][Full Text] [Related]
19. Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei.
Hirsch I; Suchánková A; Závadová H; Vonka V
Int J Cancer; 1978 Nov; 22(5):535-41. PubMed ID: 82540
[TBL] [Abstract][Full Text] [Related]
20. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
